LMR Partners LLP raised its stake in shares of Clorox Company (The) (NYSE:CLX) by 39.3% during the second quarter, according to its most recent filing with the SEC. The fund owned 9,589 shares of the company’s stock after buying an additional 2,703 shares during the period. LMR Partners LLP’s holdings in Clorox Company (The) were worth $1,278,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. Conning Inc. boosted its position in Clorox Company (The) by 2.1% in the second quarter. Conning Inc. now owns 4,762 shares of the company’s stock valued at $634,000 after buying an additional 100 shares during the period. Pinnacle Financial Partners Inc. acquired a new position in Clorox Company (The) during the second quarter valued at $386,000. UMB Bank N A MO boosted its position in Clorox Company (The) by 2.5% in the second quarter. UMB Bank N A MO now owns 14,783 shares of the company’s stock valued at $1,970,000 after buying an additional 366 shares during the period. Wedbush Securities Inc. boosted its position in Clorox Company (The) by 20.3% in the second quarter. Wedbush Securities Inc. now owns 6,554 shares of the company’s stock valued at $873,000 after buying an additional 1,108 shares during the period. Finally, Sigma Planning Corp boosted its position in Clorox Company (The) by 4.8% in the second quarter. Sigma Planning Corp now owns 21,622 shares of the company’s stock valued at $2,881,000 after buying an additional 997 shares during the period. Institutional investors and hedge funds own 69.83% of the company’s stock.

Shares of Clorox Company (NYSE CLX) opened at 137.73 on Friday. The company has a market cap of $17.78 billion, a PE ratio of 25.82 and a beta of 0.40. The firm has a 50-day moving average price of $133.55 and a 200 day moving average price of $134.12. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The firm had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.65 billion. During the same quarter last year, the firm posted $1.30 earnings per share. The company’s revenue for the quarter was up 2.9% compared to the same quarter last year. On average, equities analysts anticipate that Clorox Company will post $5.67 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This piece of content was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/20/clorox-company-the-clx-position-raised-by-lmr-partners-llp.html.

Several equities analysts have recently weighed in on the company. Jefferies Group LLC reiterated a “hold” rating and set a $137.00 price objective (up previously from $136.00) on shares of Clorox Company (The) in a report on Wednesday, August 9th. Barclays PLC reiterated an “equal weight” rating and set a $136.00 price objective (down previously from $140.00) on shares of Clorox Company (The) in a report on Friday, August 4th. BMO Capital Markets set a $150.00 price objective on Clorox Company (The) and gave the company a “buy” rating in a report on Thursday, August 3rd. Royal Bank Of Canada reiterated a “hold” rating and set a $115.00 price objective on shares of Clorox Company (The) in a report on Wednesday, August 2nd. Finally, BidaskClub upgraded Clorox Company (The) from a “strong sell” rating to a “sell” rating in a report on Monday, July 31st. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company’s stock. Clorox Company (The) currently has a consensus rating of “Hold” and a consensus price target of $129.05.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.